2026-2034年全球尿道感染試紙市場規模、佔有率、趨勢和成長分析報告

預計到 2034 年，尿道感染試紙市場規模將達到 1,016,190,000 美元，高於 2025 年的 675,610,000 美元，預計從 2026 年到 2034 年的複合年成長率將達到 4.64%。

隨著對快速便捷診斷工具的需求不斷成長，全球尿道感染（UTI）試紙市場也在穩步發展。試紙透過檢測尿液檢體中的亞硝酸鹽和白血球等物質來廣泛用於泌尿道感染疾病的診斷。由於這些試紙能夠快速提供檢測結果，因此在醫院、診所和家庭檢測等多種場景下都非常實用。

該市場成長的主要驅動力是尿道感染發生率的上升，尤其是在女性和老年人群中。早期診斷意識的提高、醫療服務可近性的改善以及家用診斷試劑盒的日益普及也促進了市場成長。診斷工具的技術進步提高了試紙的準確性和可靠性。

由於對就地檢驗解決方案的需求不斷成長，預計尿路試紙市場未來將進一步擴張。更靈敏、更易用的診斷試劑盒的開發將促進其更廣泛的應用。此外，開發中國家醫療保健成本的上升和診斷服務的擴展也將推動該市場的未來成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球尿道感染試紙市場：依類型分類

• 市場分析、洞察與預測
• 尿道炎
• 膀胱炎
• 腎盂腎炎

第5章：全球尿道感染試紙市場：依最終用途分類

• 市場分析、洞察與預測
• 全科醫生（GP）
• 泌尿系統
• 泌尿系統/婦科醫生
• 醫院檢查室
• 測試機構
• 醫院急診室
• 緊急醫療救治
• 其他

第6章：全球尿道感染試紙市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第7章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第8章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Qiagen
  • Accelerate Diagnostics Inc
  • Bio-Rad Laboratories Inc
  • F. Hoffmann-La Roche Ltd
  • Danaher
  • Siemens Healthcare GmbH
  • Randox Laboratories Ltd
  • Thermo Fisher Scientific Inc
  • Biomerieux
  • T2 Biosystems Inc

The Urinary Tract Infection Test Strip Market size is expected to reach USD 1016.19 Million in 2034 from USD 675.61 Million (2025) growing at a CAGR of 4.64% during 2026-2034.

The global urinary tract infection (UTI) test strip market is growing steadily as the demand for quick and convenient diagnostic tools increases. UTI test strips are widely used to detect infections in the urinary tract by identifying substances such as nitrites and leukocytes in urine samples. These strips provide rapid results, making them useful in hospitals, clinics, and home testing environments.

The growth of this market is mainly driven by the increasing prevalence of urinary tract infections, especially among women and elderly populations. Rising awareness about early diagnosis, improved access to healthcare services, and the growing availability of home-based diagnostic kits are also supporting market growth. Technological advancements in diagnostic tools have improved the accuracy and reliability of test strips.

Looking ahead, the UTI test strip market is expected to expand further due to the increasing demand for point-of-care testing solutions. The development of more sensitive and user-friendly diagnostic kits will likely encourage wider adoption. Additionally, increasing healthcare spending and expanding diagnostic services in developing countries will contribute to the market's future growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

• Urethritis
• Cystitis
• Pyelonephritis

By End Use

• General Practitioners (GPs)
• Urologists
• Urogynecologists
• Hospital Laboratories
• Reference Laboratories
• Hospital Emergency Departments
• Urgent Care
• Others

COMPANIES PROFILED

• Qiagen, Accelerate Diagnostics Inc, BioRad Laboratories Inc, F HoffmannLa Roche Ltd, Danaher, Siemens Healthcare GmbH, Randox Laboratories Ltd, Thermo Fisher Scientific Inc, Biomrieux, T2 Biosystems Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL URINARY TRACT INFECTION TEST STRIP MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Urethritis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Cystitis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Pyelonephritis Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL URINARY TRACT INFECTION TEST STRIP MARKET: BY END USE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast End Use
• 5.2. General Practitioners (GPs) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Urologists Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Urogynecologists Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Hospital Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Reference Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Hospital Emergency Departments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Urgent Care Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.9. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL URINARY TRACT INFECTION TEST STRIP MARKET: BY REGION 2022-2034 (USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Type
  • 6.2.2 By End Use
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Type
  • 6.3.2 By End Use
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Type
  • 6.4.2 By End Use
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Type
  • 6.5.2 By End Use
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Type
  • 6.6.2 By End Use
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL URINARY TRACT INFECTION TEST STRIP INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Qiagen
  • 8.2.2 Accelerate Diagnostics Inc
  • 8.2.3 Bio-Rad Laboratories Inc
  • 8.2.4 F. Hoffmann-La Roche Ltd
  • 8.2.5 Danaher
  • 8.2.6 Siemens Healthcare GmbH
  • 8.2.7 Randox Laboratories Ltd
  • 8.2.8 Thermo Fisher Scientific Inc
  • 8.2.9 Biomerieux
  • 8.2.10 T2 Biosystems Inc